EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:17154 - nicotinamide
| Formula | C6H6N2O |
| Net Charge | 0 |
| Average Mass | 122.127 |
| Monoisotopic Mass | 122.04801 |
| SMILES | NC(=O)c1cccnc1 |
| InChI | InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9) |
| InChIKey | DFPAKSUCGFBDDF-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Escherichia coli (ncbitaxon:562) | - | PubMed (21988831) | |
| Homo sapiens (ncbitaxon:9606) | |||
| - | MetaboLights (MTBLS292) | From MetaboLights | |
| - | MetaboLights (MTBLS266) | From MetaboLights | |
| - | MetaboLights (MTBLS263) | From MetaboLights | |
| urine (BTO:0001419) | PubMed (2026685) | ||
| blood (UBERON:0000178) | PubMed (22626821) | ||
| breast milk (ENVO:02000031) | PubMed (24027187) | ||
| - | MetaboLights (MTBLS368) | From MetaboLights | |
| - | MetaboLights (MTBLS264) | From MetaboLights | |
| - | MetaboLights (MTBLS267) | From MetaboLights | |
| - | MetaboLights (MTBLS265) | From MetaboLights | |
| - | MetaboLights (MTBLS290) | From MetaboLights | |
| - | MetaboLights (MTBLS214) | From MetaboLights | |
| - | MetaboLights (MTBLS127) | From MetaboLights | |
| Mus musculus (ncbitaxon:10090) | - | PubMed (19425150) | Source: BioModels - MODEL1507180067 |
| Saccharomyces cerevisiae (ncbitaxon:4932) | - | PubMed (24678285) | Source: yeast.sf.net |
| Roles Classification |
|---|
| Chemical Role: | antioxidant A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides. |
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor An EC 2.4.2.* (pentosyltransferase) inhibitor that interferes with the action of a NAD+ ADP-ribosyltransferase (EC 2.4.2.30). Escherichia coli metabolite Any bacterial metabolite produced during a metabolic reaction in Escherichia coli. EC 3.5.1.98 (histone deacetylase) inhibitor An EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the function of histone deacetylase (EC 3.5.1.98). Sir2 inhibitor An EC 3.5.1.98 (histone deacetylase) inhibitor that interferes with the action of Sir2. Saccharomyces cerevisiae metabolite Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ). immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. cofactor An organic molecule or ion (usually a metal ion) that is required by an enzyme for its activity. It may be attached either loosely (coenzyme) or tightly (prosthetic group). human urinary metabolite Any metabolite (endogenous or exogenous) found in human urine samples. water-soluble vitamin (role) Any vitamin that dissolves in water and readily absorbed into tissues for immediate use. Unlike the fat-soluble vitamins, they are not stored in the body and need to be replenished regularly in the diet and will rarely accumulate to toxic levels since they are quickly excreted from the body via urine. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. antiglaucoma drug Any drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision. It is often, though not always, associated with increased pressure of the fluid in the eye. geroprotector Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. renoprotective agent Any compound that is able to prevent damage to the kidneys. antipsoriatic A drug used to treat psoriasis. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anti-inflammatory agent Any compound that has anti-inflammatory effects. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. nutraceutical A product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| nicotinamide (CHEBI:17154) has functional parent nicotinic acid (CHEBI:15940) |
| nicotinamide (CHEBI:17154) has role Escherichia coli metabolite (CHEBI:76971) |
| nicotinamide (CHEBI:17154) has role Saccharomyces cerevisiae metabolite (CHEBI:75772) |
| nicotinamide (CHEBI:17154) has role anti-anaemic agent (CHEBI:75835) |
| nicotinamide (CHEBI:17154) has role anti-inflammatory agent (CHEBI:67079) |
| nicotinamide (CHEBI:17154) has role antidepressant (CHEBI:35469) |
| nicotinamide (CHEBI:17154) has role antiglaucoma drug (CHEBI:39456) |
| nicotinamide (CHEBI:17154) has role antineoplastic agent (CHEBI:35610) |
| nicotinamide (CHEBI:17154) has role antioxidant (CHEBI:22586) |
| nicotinamide (CHEBI:17154) has role antipsoriatic (CHEBI:50748) |
| nicotinamide (CHEBI:17154) has role cofactor (CHEBI:23357) |
| nicotinamide (CHEBI:17154) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| nicotinamide (CHEBI:17154) has role EC 3.5.1.98 (histone deacetylase) inhibitor (CHEBI:61115) |
| nicotinamide (CHEBI:17154) has role geroprotector (CHEBI:176497) |
| nicotinamide (CHEBI:17154) has role human urinary metabolite (CHEBI:84087) |
| nicotinamide (CHEBI:17154) has role immunosuppressive agent (CHEBI:35705) |
| nicotinamide (CHEBI:17154) has role metabolite (CHEBI:25212) |
| nicotinamide (CHEBI:17154) has role mouse metabolite (CHEBI:75771) |
| nicotinamide (CHEBI:17154) has role neuroprotective agent (CHEBI:63726) |
| nicotinamide (CHEBI:17154) has role renoprotective agent (CHEBI:231911) |
| nicotinamide (CHEBI:17154) has role Sir2 inhibitor (CHEBI:71181) |
| nicotinamide (CHEBI:17154) is a pyridine alkaloid (CHEBI:26416) |
| nicotinamide (CHEBI:17154) is a pyridinecarboxamide (CHEBI:25529) |
| nicotinamide (CHEBI:17154) is a vitamin B3 (CHEBI:176839) |
| Incoming Relation(s) |
| N-{5-[4-(4-methylpiperazin-1-yl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}nicotinamide (CHEBI:39634) has functional parent nicotinamide (CHEBI:17154) |
| N-glycosylnicotinamide (CHEBI:25526) has functional parent nicotinamide (CHEBI:17154) |
| N-methylnicotinamide (CHEBI:64399) has functional parent nicotinamide (CHEBI:17154) |
| 1-[(2-chlorophenyl)methyl]-2-oxo-6-(trifluoromethyl)-3-pyridinecarboxamide (CHEBI:114321) has functional parent nicotinamide (CHEBI:17154) |
| 1-[[oxo(3-pyridinyl)methyl]amino]-3-(4-propan-2-ylphenyl)thiourea (CHEBI:120875) has functional parent nicotinamide (CHEBI:17154) |
| 1-methylnicotinamide (CHEBI:16797) has functional parent nicotinamide (CHEBI:17154) |
| 2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-3-pyridinecarboxamide (CHEBI:91424) has functional parent nicotinamide (CHEBI:17154) |
| 2-(2,4-dimethylanilino)-N-(thiophen-2-ylmethyl)-3-pyridinecarboxamide (CHEBI:104887) has functional parent nicotinamide (CHEBI:17154) |
| 2-(4-chloro-2-methylanilino)-3-pyridinecarboxamide (CHEBI:108168) has functional parent nicotinamide (CHEBI:17154) |
| 2-(methylthio)nicotinamide (CHEBI:228655) has functional parent nicotinamide (CHEBI:17154) |
| 2-methylnicotinamide (CHEBI:68440) has functional parent nicotinamide (CHEBI:17154) |
| 2-oxo-N-(2-thiazolyl)-1H-pyridine-3-carboxamide (CHEBI:120549) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-(4-methyl-2-thiazolyl)-3-pyridinecarboxamide (CHEBI:122191) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-[(2-pyridinylamino)-sulfanylidenemethyl]-3-pyridinecarboxamide (CHEBI:120534) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-[(5-nitro-2-thiophenyl)methylideneamino]-3-pyridinecarboxamide (CHEBI:104973) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-[[(3-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-3-pyridinecarboxamide (CHEBI:93987) has functional parent nicotinamide (CHEBI:17154) |
| 5-bromo-N-[[(4-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-3-pyridinecarboxamide (CHEBI:116399) has functional parent nicotinamide (CHEBI:17154) |
| 5-hydroxy-N-[2-[[(5-hydroxy-3-pyridinyl)-oxomethyl]amino]propyl]-3-pyridinecarboxamide (CHEBI:104006) has functional parent nicotinamide (CHEBI:17154) |
| 6-methoxy-4-(trifluoromethyl)nicotinamide (CHEBI:183364) has functional parent nicotinamide (CHEBI:17154) |
| 6-methyl-N-(2-pyridinylmethylideneamino)-3-pyridinecarboxamide (CHEBI:107154) has functional parent nicotinamide (CHEBI:17154) |
| 6-methyl-N-[(2-methyl-3-phenylprop-2-enylidene)amino]-3-pyridinecarboxamide (CHEBI:105981) has functional parent nicotinamide (CHEBI:17154) |
| 6-Methylnicotinamide (CHEBI:88954) has functional parent nicotinamide (CHEBI:17154) |
| acetic acid 2-[[oxo(3-pyridinyl)methyl]amino]ethyl ester (CHEBI:92313) has functional parent nicotinamide (CHEBI:17154) |
| flumetnicam (CHEBI:231554) has functional parent nicotinamide (CHEBI:17154) |
| Himeic acid G (CHEBI:211171) has functional parent nicotinamide (CHEBI:17154) |
| hydroxymethylnicotinamide (CHEBI:134775) has functional parent nicotinamide (CHEBI:17154) |
| Myxochelin N (CHEBI:222142) has functional parent nicotinamide (CHEBI:17154) |
| Myxochelin O (CHEBI:222138) has functional parent nicotinamide (CHEBI:17154) |
| N-(1-adamantyl)-5-hydroxy-3-pyridinecarboxamide (CHEBI:104155) has functional parent nicotinamide (CHEBI:17154) |
| N-(2-fluorophenyl)-2-methyl-6-(trifluoromethyl)nicotinamide (CHEBI:189499) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2-methyl-3-phenylprop-2-enylidene)amino]-3-pyridinecarboxamide (CHEBI:105703) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118385) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118398) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:100861) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118597) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118291) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118425) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:101057) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118445) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:99262) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118736) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124890) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124301) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:100693) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2R,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118714) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124865) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124262) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:102693) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118717) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide (CHEBI:98207) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124899) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:124859) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3R,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118547) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide (CHEBI:98467) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118474) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118386) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118573) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide (CHEBI:97296) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118300) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118418) has functional parent nicotinamide (CHEBI:17154) |
| N-[(2S,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide (CHEBI:118748) has functional parent nicotinamide (CHEBI:17154) |
| N-[(3,3-dimethyl-5-oxocyclohexylidene)amino]-3-pyridinecarboxamide (CHEBI:108969) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95855) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96617) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95777) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95921) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96139) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95864) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96344) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95684) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95995) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95600) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95717) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95552) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95670) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96381) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96468) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95700) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95969) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96539) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95912) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:116657) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:110094) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:95974) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96360) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96511) has functional parent nicotinamide (CHEBI:17154) |
| N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide (CHEBI:96067) has functional parent nicotinamide (CHEBI:17154) |
| N-[[3-methoxy-4-[2-(4-methylanilino)-2-oxoethoxy]phenyl]methylideneamino]-3-pyridinecarboxamide (CHEBI:116480) has functional parent nicotinamide (CHEBI:17154) |
| N-[[5-(4-nitrophenyl)-2-furanyl]methylideneamino]-3-pyridinecarboxamide (CHEBI:116670) has functional parent nicotinamide (CHEBI:17154) |
| N-[1,1,1,3,3,3-hexafluoro-2-(2-pyridinylmethylamino)propan-2-yl]-3-pyridinecarboxamide (CHEBI:94517) has functional parent nicotinamide (CHEBI:17154) |
| N-[2-[2-[2-[[oxo(3-pyridinyl)methyl]amino]ethoxy]ethoxy]ethyl]-3-pyridinecarboxamide (CHEBI:114454) has functional parent nicotinamide (CHEBI:17154) |
| N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-3-pyridinecarboxamide (CHEBI:107956) has functional parent nicotinamide (CHEBI:17154) |
| N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]-3-pyridinecarboxamide (CHEBI:105309) has functional parent nicotinamide (CHEBI:17154) |
| N-[6-(1-oxopentylamino)-3-pyridinyl]-3-pyridinecarboxamide (CHEBI:121625) has functional parent nicotinamide (CHEBI:17154) |
| N-methyl-N-[5-(3-pyridinyl)-1,3,4-thiadiazol-2-yl]-3-pyridinecarboxamide (CHEBI:115102) has functional parent nicotinamide (CHEBI:17154) |
| N,N-Dihexylnicotinamide (CHEBI:189375) has functional parent nicotinamide (CHEBI:17154) |
| N'3-(3,4,5-trimethoxybenzylidene)pyridine-3-carbohydrazide (CHEBI:183773) has functional parent nicotinamide (CHEBI:17154) |
| nicorandil (CHEBI:31905) has functional parent nicotinamide (CHEBI:17154) |
| Nicoxamat (CHEBI:173404) has functional parent nicotinamide (CHEBI:17154) |
| nikethamide (CHEBI:134814) has functional parent nicotinamide (CHEBI:17154) |
| Penipyridone A (CHEBI:227809) has functional parent nicotinamide (CHEBI:17154) |
| Penipyridone C (CHEBI:227819) has functional parent nicotinamide (CHEBI:17154) |
| Penipyridone D (CHEBI:227822) has functional parent nicotinamide (CHEBI:17154) |
| Penipyridone F (CHEBI:227832) has functional parent nicotinamide (CHEBI:17154) |
| Pestalamide C (CHEBI:197575) has functional parent nicotinamide (CHEBI:17154) |
| Pestalamide D (CHEBI:215530) has functional parent nicotinamide (CHEBI:17154) |
| Poronitin B (CHEBI:202835) has functional parent nicotinamide (CHEBI:17154) |
| IUPAC Name |
|---|
| pyridine-3-carboxamide |
| INNs | Source |
|---|---|
| nicotinamida | WHO MedNet |
| nicotinamide | WHO MedNet |
| nicotinamide | WHO MedNet |
| nicotinamidum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 3-carbamoylpyridine | ChemIDplus |
| 3-pyridinecarboxamide | NIST Chemistry WebBook |
| m-(aminocarbonyl)pyridine | ChemIDplus |
| niacin | ChEBI |
| Niacinamid | ChEMBL |
| niacinamide | ChEMBL |
| Brand Names | Source |
|---|---|
| Freederm | ChEMBL |
| Niacinamide component of tpn | ChEMBL |
| Niacinamide component of vitaped | ChEMBL |
| Niatin | ChEMBL |
| Nicam | ChEMBL |
| UniProt Name | Source |
|---|---|
| nicotinamide | UniProt |
| Manual Xrefs | Databases |
|---|---|
| 1906 | DrugCentral |
| C00000209 | KNApSAcK |
| C00153 | KEGG COMPOUND |
| D00036 | KEGG DRUG |
| DB02701 | DrugBank |
| FDB012485 | FooDB |
| HMDB0001406 | HMDB |
| LSM-5428 | LINCS |
| NCA | PDBeChem |
| NIACINAMIDE | MetaCyc |
| Nicotinamide | Wikipedia |
| US2904552 | Patent |
| US2993051 | Patent |
| Citations |
|---|